Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
29.91
+0.35 (1.18%)
At close: Dec 5, 2025, 4:00 PM EST
29.92
0.00 (0.02%)
After-hours: Dec 5, 2025, 5:01 PM EST
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $4.37 billion as of December 5, 2025. Its market cap has increased by 96.90% in one year.
Market Cap
4.37B
Enterprise Value
4.24B
1-Year Change
96.90%
Ranking
Category
Stock Price
$29.91
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $4.37B, an increase of 149.88%. That is a compound annual growth rate of 22.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4.37B | 97.84% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |